Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373997 · ClinicalTrials.gov registry record · Phase 4
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
A Phase 4 study of Gastroesophageal Reflux and Larynx Disease, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT00373997: Completed Phase 4 study of Gastroesophageal Reflux and Larynx Disease, sponsored by Vanderbilt University.
NCT00373997 is a Phase 4 study of Gastroesophageal Reflux and Larynx Disease that has completed, run by Vanderbilt University. The registered enrollment target is 45 participants, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00373997, a Phase 4 study of Gastroesophageal Reflux and Larynx Disease, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether patients with suspected Laryngopharyngeal reflux have inflammation and ultrastructural injury on their laryngeal biopsies.
Conditions Studied
Interventions
- PROCEDURE Esophageal and Laryngeal biopsies
- PROCEDURE egd with biopsy
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center, Endoscopy Lab, TVC 1410 - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
What the finished NCT00373997 record still lists
NCT00373997 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 2 interventions - of which Esophageal and Laryngeal biopsies is the first listed.
NCT00373997 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00373997 about?
NCT00373997 is a clinical study titled "Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux". The purpose of the study is to determine whether patients with suspected Laryngopharyngeal reflux have inflammation and ultrastructural injury on their laryngeal biopsies.
What is the current status of trial NCT00373997?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2006-09. Estimated completion is 2009-12.
What conditions does trial NCT00373997 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux, Larynx Disease.
What interventions are being tested in trial NCT00373997?
The interventions under investigation include: Esophageal and Laryngeal biopsies (PROCEDURE), egd with biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00373997?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00373997 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00373997's enrollment target sits among peer trials
45 24th of 33 higher than 10 of 33 other Gastroesophageal Reflux trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroesophageal Reflux trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gastrointestinal Dysmotility on Aspiration Risk
RECRUITING · Phase 4
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Barrett's Esophagus Related Neoplasia (BERN) Project
RECRUITING
-
External UES Band (Shaker Pressure Band) and GERD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia